Published in PLoS One on May 25, 2012
Strengthening the expanded programme on immunization in Africa: looking beyond 2015. PLoS Med (2013) 1.32
Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews. BMC Public Health (2012) 1.20
Hepatitis B virus: where do we stand and what is the next step for eradication? World J Gastroenterol (2014) 1.03
Vaccine coverage and determinants of incomplete vaccination in children aged 12-23 months in Dschang, West Region, Cameroon: a cross-sectional survey during a polio outbreak. BMC Public Health (2015) 1.00
A bibliometric analysis of childhood immunization research productivity in Africa since the onset of the Expanded Program on Immunization in 1974. BMC Med (2013) 0.94
Urban settings do not ensure access to services: findings from the immunisation programme in Kampala Uganda. BMC Health Serv Res (2014) 0.91
Understanding interventions for improving routine immunization coverage in children in low- and middle-income countries: a systematic review protocol. Syst Rev (2013) 0.89
Innovations in communication technologies for measles supplemental immunization activities: lessons from Kenya measles vaccination campaign, November 2012. Health Policy Plan (2014) 0.87
Individual and community level determinants of childhood full immunization in Ethiopia: a multilevel analysis. BMC Public Health (2015) 0.82
Trends in the types and quality of childhood immunisations research output from Africa 1970-2010: mapping the evidence base. BMC Health Serv Res (2014) 0.80
Maiden immunization coverage survey in the republic of South Sudan: a cross-sectional study providing baselines for future performance measurement. Pan Afr Med J (2013) 0.80
Exploring models for the roles of health systems' responsiveness and social determinants in explaining universal health coverage and health outcomes. Glob Health Action (2016) 0.78
Survival Analysis for Predictive Factors of Delay Vaccination in Iranian Children. Int J Prev Med (2015) 0.78
Why children are not vaccinated against measles: a cross-sectional study in two Nigerian States. Arch Public Health (2014) 0.77
The influence of compositional and contextual factors on non-receipt of basic vaccines among children of 12-23-month old in India: a multilevel analysis. PLoS One (2014) 0.76
Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference. Pan Afr Med J (2016) 0.76
Does an education seminar intervention improve the parents' knowledge on vaccination? Evidence from Yiwu, East China. Int J Environ Res Public Health (2015) 0.75
Determinants of childhood vaccination completion at a peri-urban hospital in Kenya, December 2013 -January 2014: a case control study. Pan Afr Med J (2015) 0.75
Protocol for a systematic review of the effects of interventions to inform or educate caregivers about childhood vaccination in low and middle-income countries. BMJ Open (2015) 0.75
Demand- and supply-side determinants of diphtheria-pertussis-tetanus nonvaccination and dropout in rural India. Vaccine (2017) 0.75
Timely immunization completion among children in Vietnam from 2000 to 2011: a multilevel analysis of individual and contextual factors. Glob Health Action (2016) 0.75
Interventions for improving coverage of childhood immunisation in low- and middle-income countries. Cochrane Database Syst Rev (2016) 0.75
Incomplete childhood immunization in Nigeria: a multilevel analysis of individual and contextual factors. BMC Public Health (2017) 0.75
Does an educational intervention improve parents' knowledge about immunization? Experience from Malaysia. BMC Pediatr (2014) 0.75
Electronic and postal reminders for improving immunisation coverage in children: protocol for a systematic review and meta-analysis. BMJ Open (2015) 0.75
[Immunization coverage and factors associated with drop-out in children 12 to 23 months in Djoungolo-Cameroon Health District in 2012]. Pan Afr Med J (2014) 0.75
Acceptance of a malaria vaccine by caregivers of sick children in Kenya. Malar J (2014) 0.75
The acceptability of three vaccine injections given to infants during a single clinic visit in South Africa. BMC Public Health (2016) 0.75
Prevalence and associated factors of partially/non-immunization of under-five in Goma city, Democratic Republic of Congo: a community-based cross-sectional survey. Pan Afr Med J (2015) 0.75
Predictors of Uptake and Timeliness of Newly Introduced Pneumococcal and Rotavirus Vaccines, and of Measles Vaccine in Rural Malawi: A Population Cohort Study. PLoS One (2016) 0.75
Challenges faced by professional nurses when implementing the Expanded Programme on Immunisation at rural clinics in Capricorn District, Limpopo. Afr J Prim Health Care Fam Med (2016) 0.75
Parental investment in child health in sub-Saharan Africa: a cross-national study of health-seeking behaviour. R Soc Open Sci (2016) 0.75
Risk Factors of Delay Proportional Probability in Diphtheria-tetanus-pertussis Vaccination of Iranian Children; Life Table Approach Analysis. J Glob Infect Dis (2016) 0.75
Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet (2010) 26.48
Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. Am J Epidemiol (2005) 7.35
Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med (2010) 6.56
A brief conceptual tutorial of multilevel analysis in social epidemiology: linking the statistical concept of clustering to the idea of contextual phenomenon. J Epidemiol Community Health (2005) 5.44
Mass media interventions: effects on health services utilisation. Cochrane Database Syst Rev (2002) 4.75
Patient reminder and patient recall systems to improve immunization rates. Cochrane Database Syst Rev (2005) 4.02
Interpreting parameters in the logistic regression model with random effects. Biometrics (2000) 3.64
The neighborhood context of well-being. Perspect Biol Med (2003) 3.04
A systematic review on communicating with patients about evidence. J Eval Clin Pract (2006) 2.91
Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: findings from a systematic review of the published literature, 1999-2009. Vaccine (2011) 2.70
Assessment of factors associated with complete immunization coverage in children aged 12-23 months: a cross-sectional study in Nouna district, Burkina Faso. BMC Int Health Hum Rights (2009) 2.00
The effects and costs of expanding the coverage of immunisation services in developing countries: a systematic literature review. Vaccine (2005) 1.95
Too little but not too late: results of a literature review to improve routine immunization programs in developing countries. BMC Health Serv Res (2008) 1.69
Using immunization delivery strategies to accelerate progress in Africa towards achieving the Millennium Development Goals. Vaccine (2008) 1.65
Inequitable childhood immunization uptake in Nigeria: a multilevel analysis of individual and contextual determinants. BMC Infect Dis (2009) 1.55
Interventions for improving coverage of child immunization in low- and middle-income countries. Cochrane Database Syst Rev (2011) 1.51
Determinants of the uptake of the full dose of diphtheria-pertussis-tetanus vaccines (DPT3) in Northern Nigeria: a multilevel analysis. Matern Child Health J (2008) 1.44
Coverage and costs of childhood immunizations in Cameroon. Bull World Health Organ (2004) 1.38
The costs, effects and cost-effectiveness of strategies to increase coverage of routine immunizations in low- and middle-income countries: systematic review of the grey literature. Bull World Health Organ (2004) 1.35
Faith and child survival: the role of religion in childhood immunization in Nigeria. J Biosoc Sci (2008) 1.25
Strengthening research capacity. Lancet (2002) 1.18
Rates of coverage and determinants of complete vaccination of children in rural areas of Burkina Faso (1998-2003). BMC Public Health (2009) 1.10
Make the money work for health in sub-Saharan Africa. Lancet (2009) 1.09
Accelerated measles control in sub-Saharan Africa. Lancet (2006) 1.09
Minding the immunization gap: family characteristics associated with completion rates in rural Ethiopia. J Community Health (2010) 1.02
Immunization status and its determinants among children of female traders in Ibadan, South-Western Nigeria. Afr J Med Med Sci (2009) 1.00
Effectiveness of the oral polio vaccine and prospects for global eradication of polio. Trop Doct (2007) 0.83
Risk factors for measles in young infants in an urban African area with high measles vaccination coverage. Pediatr Infect Dis J (2011) 0.82
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet (2013) 8.18
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (2008) 4.21
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Current status and future prospects of epidemiology and public health training and research in the WHO African region. Int J Epidemiol (2012) 3.60
Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol (2008) 3.19
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis (2014) 2.65
Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods (2004) 2.50
Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents. Am J Respir Crit Care Med (2012) 2.32
Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol (2008) 2.27
Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur J Immunol (2010) 2.25
Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. J Infect Dis (2011) 2.24
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J Infect Dis (2008) 2.05
The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am J Respir Crit Care Med (2010) 2.03
Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev (2010) 1.94
Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev (2012) 1.77
Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis (2007) 1.72
Bacillus Calmette-Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy. Int J Infect Dis (2008) 1.66
The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis (2006) 1.64
Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review. BMC Infect Dis (2013) 1.57
Development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance. J Clin Microbiol (2010) 1.52
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine (2009) 1.45
The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One (2011) 1.42
Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response. J Immunol (2006) 1.40
European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership. BMC Public Health (2009) 1.35
Strengthening the expanded programme on immunization in Africa: looking beyond 2015. PLoS Med (2013) 1.32
A prospective, cross-sectional study of anaemia and peripheral iron status in antiretroviral naïve, HIV-1 infected children in Cape Town, South Africa. BMC Infect Dis (2002) 1.32
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults. Am J Respir Crit Care Med (2013) 1.31
Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines. Clin Infect Dis (2009) 1.28
Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews. BMC Public Health (2012) 1.20
Early warning indicators for HIV drug resistance in Cameroon during the year 2010. PLoS One (2012) 1.16
Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis. BMC Med (2009) 1.14
Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population. AIDS (2012) 1.12
HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine. J Infect Dis (2009) 1.12
'Communicate to vaccinate' (COMMVAC). building evidence for improving communication about childhood vaccinations in low- and middle-income countries: protocol for a programme of research. Implement Sci (2011) 1.12
Risk factors and a predictive model for under-five mortality in Nigeria: evidence from Nigeria demographic and health survey. BMC Pregnancy Childbirth (2012) 1.12
A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults. Am J Respir Crit Care Med (2012) 1.09
Individual and contextual factors associated with childhood stunting in Nigeria: a multilevel analysis. Matern Child Nutr (2011) 1.09
Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. J Affect Disord (2012) 1.08
Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease. Vaccine (2010) 1.03
Growth and micronutrient disturbances in stable, HIV-infected children in Cape Town. Ann Trop Paediatr (2002) 1.01
The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa. Pediatr Infect Dis J (2006) 0.99
Prevalence and predictors of major depression in HIV-infected patients on antiretroviral therapy in Bamenda, a semi-urban center in Cameroon. PLoS One (2012) 0.99
Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: a case of immune reconstitution inflammatory syndrome. Pediatr Infect Dis J (2004) 0.94
A bibliometric analysis of childhood immunization research productivity in Africa since the onset of the Expanded Program on Immunization in 1974. BMC Med (2013) 0.94
Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings. BMC Public Health (2013) 0.94
Making BCG vaccination programmes safer in the HIV era. Lancet (2008) 0.90
Impact of malaria on hematological parameters in people living with HIV/AIDS attending the Laquintinie Hospital in Douala, Cameroon. PLoS One (2012) 0.90
Prevalence of Hypertension in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.89
Factors that affect the uptake of community-based health insurance in low-income and middle-income countries: a systematic protocol. BMJ Open (2014) 0.89
Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol. Syst Rev (2013) 0.89
Understanding interventions for improving routine immunization coverage in children in low- and middle-income countries: a systematic review protocol. Syst Rev (2013) 0.89
Review of rotavirus studies in Africa: 1976-2006. J Infect Dis (2010) 0.89
Some social determinants of urinary schistosomiasis in Northern Cameroon: implications for schistosomiasis control. Afr J Health Sci (2007) 0.88
Determining causes of mortality in children enrolled in a vaccine field trial in a rural area in the Western Cape Province of South Africa. J Paediatr Child Health (2007) 0.88
The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocol. BMJ Open (2014) 0.88
Pattern and determinants of HIV research productivity in sub-Saharan Africa: bibliometric analysis of 1981 to 2009 PubMed papers. BMC Infect Dis (2010) 0.88
Incidence and Diagnosis of Pertussis in South African Children Hospitalized With Lower Respiratory Tract Infection. Pediatr Infect Dis J (2016) 0.88
Exploring variations in childhood stunting in Nigeria using league table, control chart and spatial analysis. BMC Public Health (2013) 0.88
An update of malaria infection and anaemia in adults in Buea, Cameroon. BMC Res Notes (2010) 0.87
Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life. Clin Immunol (2008) 0.87
Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis. BMC Infect Dis (2012) 0.87
Field evaluation of Calypte's AWARE blood serum plasma (BSP) and oral mucosal transudate (OMT) rapid tests for detecting antibodies to HIV-1 and 2 in plasma and oral fluid. Open AIDS J (2009) 0.86
The impact of mass media interventions on tuberculosis awareness, health-seeking behaviour and health service utilisation: a systematic review protocol. BMJ Open (2014) 0.85
Hematuria and dysuria in the self-diagnosis of urinary schistosomiasis among school-children in Northern Cameroon. Afr J Health Sci (2007) 0.85
Yellow fever control in Cameroon: where are we now and where are we going? BMC Med (2008) 0.84
Developing vaccinology expertise for Africa: six years and counting. Vaccine (2011) 0.84
Sexual behavior of HIV-positive women in Cameroon. J Int Assoc Provid AIDS Care (2011) 0.84
Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin. Pediatr Infect Dis J (2002) 0.83
The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative. Pan Afr Med J (2011) 0.83
Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women. Cochrane Database Syst Rev (2011) 0.83
Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 0.83
High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible? Cancer Epidemiol (2011) 0.82
Lessons and myths in the HIV/AIDS response. Lancet (2009) 0.81
Trends in the types and quality of childhood immunisations research output from Africa 1970-2010: mapping the evidence base. BMC Health Serv Res (2014) 0.80
Adherence to Antiretroviral Therapy for the Success of Emerging Interventions to Prevent HIV Transmission: A Wake up Call. J AIDS Clin Res (2013) 0.79
Social disorganization and history of child sexual abuse against girls in sub-Saharan Africa: a multilevel analysis. BMC Int Health Hum Rights (2013) 0.79
Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study. BMC Neurol (2013) 0.79
Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: a cross-sectional study. BMC Res Notes (2012) 0.78
Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens. AIDS (2016) 0.78
Bacteriuria amongst pregnant women in the Buea Health District, Cameroon: prevalence, predictors, antibiotic susceptibility patterns and diagnosis. PLoS One (2013) 0.77
HIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral load. AIDS Res Hum Retroviruses (2011) 0.77
Impact of antiretroviral therapy on glycemia and transaminase levels in patients living with HIV/AIDS in Limbe, Cameroon. J Int Assoc Provid AIDS Care (2012) 0.77
Use of systematic reviews in WHO recommendations. Lancet (2011) 0.77
Interventions for the prevention of mycobacterium avium complex in adults and children with HIV. Cochrane Database Syst Rev (2013) 0.76
The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children. Pediatr Infect Dis J (2015) 0.75
Safety of licensed vaccines in HIV-infected persons: a systematic review protocol. Syst Rev (2014) 0.75
Individual and community-level socioeconomic position and its association with adolescents experience of childhood sexual abuse: a multilevel analysis of six countries in Sub-Saharan Africa. J Inj Violence Res (2013) 0.75
Meta-analysis of randomized controlled trials on the treatment of pulmonary arterial hypertension. Circ J (2010) 0.75
Public stewardship of private for-profit healthcare providers in low- and middle-income countries. Cochrane Database Syst Rev (2016) 0.75
Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon. BMC Res Notes (2012) 0.75
Knowledge, attitudes and practices on adolescent vaccination among parents, teachers and adolescents in Africa: a systematic review protocol. Syst Rev (2014) 0.75
Interventions for HIV-associated nephropathy. Cochrane Database Syst Rev (2013) 0.75
Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis. J Acquir Immune Defic Syndr (2017) 0.75
Universal access to antiretroviral therapy: are we moving the targets? J Int Assoc Physicians AIDS Care (Chic) (2009) 0.75
SATVI - after 10 years closing in on a new and better vaccine to prevent tuberculosis. S Afr Med J (2012) 0.75